Evidence map›Paper›PMID 37867213›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

A Bacterial mRNA-Lysis-Mediated Cargo Release Vaccine System for Regulated Cytosolic Surveillance and Optimized Antigen Delivery.

Yu-An Li, Yanni Sun, Yuqin Zhang, Quan Li, Shifeng Wang, Roy Curtiss, Huoying Shi

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Recombinant AttenuatedBiomolecules · 2026
    Article
  4. Article
  5. Article
  6. A Purely Biomanufactured System for Delivering Nanoparticles and STING Agonists.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Yu-An LiCollege of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, 225000, China.
Yanni SunCollege of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, 225000, China.
Yuqin ZhangCollege of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, 225000, China.
Quan LiCollege of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, 225000, China.
Shifeng WangDepartment of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida, Gainesville, FL, 32611-0880, USA.
Roy CurtissDepartment of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida, Gainesville, FL, 32611-0880, USA.
Huoying ShiCollege of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, 225000, China.ORCID 0000-0003-4128-329X
Yangzhou University · CNUniversity of Florida · US

Funding

Title: Manipulate cell surface by triple sugars for broad-spectrum Salmonella vaccine developmentR21AI126172 · NIAID · UNIVERSITY OF FLORIDA · PI WANG, SHIFENG · 2017 to 2018
$419k
111 Project D18007BLRD VA I01 BX006075Jiangsu Province Science and Technology Program Special Fund Project BZ2022042National Natural Science Foundation of China 30670079National Natural Science Foundation of China 31172300National Natural Science Foundation of China 31672516National Natural Science Foundation of China 32002301National Natural Science Foundation of China 32172802NIAID NIH HHS R21 AI126172Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
6 · The paper itself

Abstract

Engineered vector-based in vivo protein delivery platforms have made significant progress for both prophylactic and therapeutic applications. However, the lack of effective release strategies results in foreign cargo being trapped within the vector, restricting the provision of significant performance benefits and enhanced therapeutic results compared to traditional vaccines. Herein, the development of a Salmonella mRNA interferase regulation vector (SIRV) system is reported to overcome this challenge. The genetic circuits are engineered that (1) induce self-lysis to release foreign antigens into target cells and (2) activate the cytosolic surveillance cGAS-STING axis by releasing DNA into the cytoplasm. Delayed synthesis of the MazF interferase regulates differential mRNA cleavage, resulting in a 36-fold increase in the delivery of foreign antigens and modest activation of the inflammasome, which collectively contribute to the marked maturation of antigen-presenting cells (APCs). Bacteria delivering the protective antigen SaoA exhibits excellent immunogenicity and safety in mouse and pig models, significantly improving the survival rate of animals challenged with multiple serotypes of Streptococcus suis. Thus, the SIRV system enables the effective integration of various modular components and antigen cargos, allowing for the generation of an extensive range of intracellular protein delivery systems using multiple bacterial species in a highly efficient manner.

Indexed as

Antigens, BacterialBacterial VaccinesAnimalsBacteriaCell DeathMiceRNA, MessengerSwineAntigens, BacterialBacterial VaccinesRNA, MessengercGAS-STINGcytosolic surveillanceMazF interferaseSalmonella

Identifiers

PMID37867213
PMCPMC10667801
OpenAlexW4387866522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.